Literature DB >> 11858978

Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer.

P Fayers1, A Bottomley.   

Abstract

In forming its Quality of Life Group, the EORTC created one of the earliest and largest of such groups in Europe. The EORTC QLQ-C30 which this group developed has become the most widely used questionnaire in Europe for cancer patients, and is extensively used around the world. The Quality of Life Group continues to build upon this success, both by refining the QLQ-C30, whilst developing a range of additional modules, and by initiating research projects that explore aspects of quality of life assessment, evaluation and interpretation. We review the progress to date and indicate directions of further research and development.

Entities:  

Mesh：

Year:  2002        PMID： 11858978     DOI： 10.1016/s0959-8049(01)00448-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


  171 in total

1.  Development of a lack of appetite item bank for computer-adaptive testing (CAT).

Authors:  Lise Holst Thamsborg; Morten Aa Petersen; Neil K Aaronson; Wei-Chu Chie; Anna Costantini; Bernhard Holzner; Irma M Verdonck-de Leeuw; Teresa Young; Mogens Groenvold
Journal:  Support Care Cancer       Date:  2014-11-14       Impact factor: 3.603

2.  Psychometric testing of the Chinese-version cancer needs questionnaire short form head and neck cancer-specific version in oral cavity cancer patients.

Authors:  Shu-Ching Chen; Yeur-Hur Lai; Sue-Yueh Cheng; Chun-Ta Liao; Joseph Tung-Chien Chang
Journal:  Support Care Cancer       Date:  2010-04-28       Impact factor: 3.603

3.  Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial.

Authors:  Michela Del Prete; François-Alexandre Buteau; Frédéric Arsenault; Nassim Saighi; Louis-Olivier Bouchard; Alexis Beaulieu; Jean-Mathieu Beauregard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-11-30       Impact factor: 9.236

4.  Measurement of patient-reported outcomes after laparoscopic cholecystectomy: a systematic review.

Authors:  Harry C Alexander; Cindy H Nguyen; Matthew R Moore; Adam S Bartlett; Jacqueline A Hannam; Garth H Poole; Alan F Merry
Journal:  Surg Endosc       Date:  2019-04-01       Impact factor: 4.584

5.  Development of computerized adaptive testing (CAT) for the EORTC QLQ-C30 physical functioning dimension.

Authors:  Morten Aa Petersen; Mogens Groenvold; Neil K Aaronson; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Peter Fayers; Jorunn Helbostad; Bernhard Holzner; Stein Kaasa; Susanne Singer; Galina Velikova; Teresa Young
Journal:  Qual Life Res       Date:  2010-10-23       Impact factor: 4.147

6.  Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.

Authors:  Srinivas Raman; Keyue Ding; Edward Chow; Ralph M Meyer; Yvette M van der Linden; Daniel Roos; William F Hartsell; Peter Hoskin; Jackson S Y Wu; Abdenour Nabid; Rick Haas; Ruud Wiggenraad; Scott Babington; William F Demas; Carolyn F Wilson; Rebecca K S Wong; Liting Zhu; Michael Brundage
Journal:  Qual Life Res       Date:  2017-11-29       Impact factor: 4.147

7.  Income and health-related quality of life among prostate cancer patients over a one-year period after radical prostatectomy: a linear mixed model analysis.

Authors:  Jens Klein; Daniel Lüdecke; Kerstin Hofreuter-Gätgens; Margit Fisch; Markus Graefen; Olaf von dem Knesebeck
Journal:  Qual Life Res       Date:  2017-04-25       Impact factor: 4.147

Review 8.  Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.

Authors:  Krzysztof Adamowicz
Journal:  Qual Life Res       Date:  2016-10-13       Impact factor: 4.147

9.  Psychometric evaluation of the EORTC computerized adaptive test (CAT) fatigue item pool.

Authors:  Morten Aa Petersen; Johannes M Giesinger; Bernhard Holzner; Juan I Arraras; Thierry Conroy; Eva-Maria Gamper; Madeleine T King; Irma M Verdonck-de Leeuw; Teresa Young; Mogens Groenvold
Journal:  Qual Life Res       Date:  2013-02-28       Impact factor: 4.147

10.  Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.

Authors:  T Conroy; M Hebbar; J Bennouna; M Ducreux; M Ychou; G Llédo; A Adenis; R Faroux; C Rebischung; L Kockler; J Y Douillard
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.